(Q43818359)

27 November 2017

title

Indications, results, and complications of tacrolimus conversion in pediatric renal transplantation (English)

1 reference

27 November 2017

Flynn JT

1

1 reference

27 November 2017

Bunchman TE

series ordinal

2

1 reference

27 November 2017

Sherbotie JR

series ordinal

3

1 reference

27 November 2017

language of work or name

1 reference

1 December 2001

1 reference

Pediatric Transplantation

27 November 2017

published in

1 reference

27 November 2017

volume

5

1 reference

27 November 2017

issue

6

1 reference

27 November 2017

page(s)

439-446

1 reference

A prospective randomized trial of FK506-based immunosuppression after renal transplantation

27 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3046.2001.T01-1-00042.X

A risk-benefit assessment of tacrolimus in transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3046.2001.T01-1-00042.X

7 January 2021

Tacrolimus: immunosuppression following liver and kidney transplant

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3046.2001.T01-1-00042.X

7 January 2021

An open-label, concentration-ranging trial of FK506 in primary kidney transplantation: a report of the United States Multicenter FK506 Kidney Transplant Group

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3046.2001.T01-1-00042.X

7 January 2021

https://api.crossref.org/works/10.1034%2FJ.1399-3046.2001.T01-1-00042.X

1 reference

7 January 2021

A multicenter trial of FK506 (tacrolimus) therapy in refractory acute renal allograft rejection. A report of the Tacrolimus Kidney Transplantation Rescue Study Group

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3046.2001.T01-1-00042.X

7 January 2021

Tacrolimus rescue therapy for renal allograft rejection--five-year experience

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3046.2001.T01-1-00042.X

7 January 2021

Treatment of cyclosporine-related adverse effects by conversion to tacrolimus after liver transplantation

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3046.2001.T01-1-00042.X

7 January 2021

Steady improvement in renal allograft survival among North American children: a five year appraisal by the North American Pediatric Renal Transplant Cooperative Study.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3046.2001.T01-1-00042.X

7 January 2021

FK506 in pediatric kidney transplantation--primary and rescue experience

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3046.2001.T01-1-00042.X

7 January 2021

Improved renal allograft survival in children treated with FK 506 (tacrolimus) rescue therapy

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3046.2001.T01-1-00042.X

7 January 2021

Long-term results after conversion from cyclosporine to tacrolimus in pediatric liver transplantation for acute and chronic rejection

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3046.2001.T01-1-00042.X

7 January 2021

Tacrolimus: the good, the bad, and the ugly

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3046.2001.T01-1-00042.X

7 January 2021

Tacrolimus and myocardial hypertrophy

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3046.2001.T01-1-00042.X

7 January 2021

The effect of conversion from cyclosporine to tacrolimus on gingival hyperplasia, hirsutism and cholesterol

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3046.2001.T01-1-00042.X

7 January 2021

10.1034/J.1399-3046.2001.T01-1-00042.X

Identifiers

DOI

1 reference

27 November 2017

1 reference